Karyopharm Therapeutics Inc. sell goldmanns
Start price
18.02.24
/
0%
€1.22
Target price
18.02.25
-
Performance (%)
-12.61%
Price
17.05.24
€1.07
Summary
This prediction is currently active. The prediction for Karyopharm Therapeutics Inc. shows a convincing performance of -12.61%. This prediction currently runs until 18.02.25. The prediction end date can be changed by goldmanns at any time. This prediction was marked as speculative and is excluded from goldmanns's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | 1.861% | 1.861% |
| iShares Core DAX® | 0.051% | 5.593% |
| iShares Nasdaq 100 | 1.808% | 7.445% |
| iShares Nikkei 225® | 2.181% | 2.815% |
| iShares S&P 500 | 1.040% | 4.975% |
Comments by goldmanns for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Sell Karyopharm Therapeutics Inc.